Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

Ozaslan, ErsinOzkan, MetinCicin, IrfanBenekli, MustafaKocer, MuratUysal, MukreminOksuzoglu, Berna2024-04-242024-04-2420170732-183X1527-7755https://doi.org/10.1200/JCO.2017.35.15_suppl.e21656https://hdl.handle.net/11468/1830153rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 02-07, 2017 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).Conference Object35WOS:00041193220518910.1200/JCO.2017.35.15_suppl.e21656Q1